Issue

Vol. 66 No. 5: Issue 5

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Effects of oral desloratadine citrate disodium combined with physiological seawater nasal irrigation on IgE levels, IL-4, IL-6, IL-13 and IFN-γ expression and treatment of intermittent allergic rhinitis

https://doi.org/10.14715/cmb/2020.66.5.11
Yuanyuan Zhang
Department of Otolaryngology Head and Neck Surgery, Jining NO.1 People's Hospital, Jining, 272000, China
Wei Li
Department of Otolaryngology Head and Neck Surgery, Jining NO.1 People's Hospital, Jining, 272000, China

Corresponding Author(s) : Wei Li

WeiLi22334455@163.com

Cellular and Molecular Biology, Vol. 66 No. 5: Issue 5

Abstract

This experiment was performed to explore the effect of oral desloratadine citrate disodium combined with physiological seawater nasal irrigation in the treatment of intermittent allergic rhinitis and its effect on serum inflammatory factors and peripheral blood Th1 and Th2. For this purpose, 100 patients of intermittent allergic rhinitis admitted to our hospital from January 2018 to January 2020. Randomly divided into a control group (n=50) and an observation group (n=50). The control group was given oral desloratadine citrate disodium. The observation group was given physiological seawater nasal irrigation based on the control group. Both groups were treated for one month. Compare the effect of treatment, symptom and sign scores pre and posttreatment, serum immunoglobulin E (IgE) levels, serum interleukin 4 (IL-4), IL-6, IL-13 and interferon-gamma (IFN-γ) levels, peripheral blood helper T cells 1 (Th1) and Th2 and the recurrence rate of patients after 1 year between two groups. Results showed that after one month of continuous treatment, the total effective rate of the observation group was significantly higher than that of the control group (P <0.05). The symptoms and signs scores and serum IgE levels of the two groups pretreatment (before treatment) were not significantly different (P > 0.05). The symptoms and signs scores and serum IgE levels of the two groups decreased significantly posttreatment (after treatment) (P <0.05), and the observation group was significantly lower than the control group (P <0.05). Pretreatment, the levels of serum inflammatory factors (IL-4, IL-6, IL-13, and IFN-γ) and the ratio of peripheral blood Th1 and Th2 to CD4+T cells were not significantly different (P> 0.05). After one month of continuous treatment, the levels of serum IL-4, IL-6, IL-13, and the ratio of peripheral blood CD4+IL-4+/CD4+ in the observation group and the control group were significantly reduced and the ratio of CD4+IFN-γ+/CD4+ was significantly increased (P <0.05). Compared with the control group, those changes were more obvious in the observation group (P <0.05). The one-year recurrence rate of the observation group was 4% (2/50), which was significantly lower than that of the control group, which was 20% (10/50). There was a statistical difference between the two groups (P <0.05). It was concluded that oral desloratadine citrate disodium combined with physiological seawater nasal irrigation can effectively improve the symptoms and signs of intermittent allergic rhinitis and reduce the recurrence rate. This may be related to balancing T cell responses, promoting systemic Th1 responses and inhibiting Th2 responses, and down-regulating inflammatory response.

Keywords

desloratadine citrate disodium intermittent allergic rhinitis Physiological sea nasal irrigation
Zhang, Y., & Li, W. (2020). Effects of oral desloratadine citrate disodium combined with physiological seawater nasal irrigation on IgE levels, IL-4, IL-6, IL-13 and IFN-γ expression and treatment of intermittent allergic rhinitis. Cellular and Molecular Biology, 66(5), 54–58. https://doi.org/10.14715/cmb/2020.66.5.11
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Silkoff PE, Robbins RA, Gaston B, Lundberg JO, Townley RG. Endogenous nitric oxide in allergic airway disease. J Allergy Clin Immunol 2000; 105: 438-448.
  2. Hoyte FCL, Nelson HS, Recent advances in allergic rhinitis. F1000Res 2018;7.
  3. Meltzer EO, Allergic Rhinitis: Burden of Illness, Quality of Life, Comorbidities, and Control. Immunol Allergy Clin North Am 2016; 36: 235-248.
  4. Rabago D, Pasic T, Zgierska A, Mundt M, Barrett B, Maberry R. The efficacy of hypertonic saline nasal irrigation for chronic sinonasal symptoms. Otolaryngol Head Neck Surg 2005; 133: 3-8.
  5. Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hörmann K, Maurer JT. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004; 113: 663-668.
  6. Dass K, Petrusan AJ, Beaumont J, Zee P, Lai JS, Fishbein A. Assessment of sleep disturbance in children with allergic rhinitis. Ann Allergy Asthma Immunol 2017; 118: 505-506.
  7. Bahekar PC, Shah JH, Ayer UB, Mandhane SN, Thennati R. Validation of guinea pig model of allergic rhinitis by oral and topical drugs. Int Immunopharmacol 2008; 8: 1540-1551.
  8. Cuppari C, Leonardi S, Manti S, Filippelli M, Alterio T, Spicuzza L, Rigoli L, Arrigo T, Lougaris V, Salpietro C. Allergen immunotherapy, routes of administration and cytokine networks: an update. Immunotherapy 2014; 6: 775-786.
  9. Motala C, H1 antihistamines in allergic disease. Current Allergy & Clinical Immunology 2009; 22(2):71-4.
  10. Mizuguchi H, Ono S, Hattori M, Fukui H. Inverse Agonistic Activity of Antihistamines and Suppression of Histamine H(1) Receptor Gene Expression. J Pharmacol Sci 2012; 118: 117-121.
  11. Subspecialty Group of Rhinology EB. Chinese guidelines for diagnosis and treatment of allergic rhinitis. Zhonghua er bi yan hou tou jing wai ke za zhi= Chinese journal of otorhinolaryngology head and neck surgery. 2016; 51(1):6.
  12. Bousquet J, Jacquot W, Vignola AM, Bachert C, Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways?. J Allergy Clin Immunol 2004; 113: 43-49.
  13. Scadding G, Predicting and establishing the clinical efficacy of a histamine h(1)-receptor antagonist: desloratadine, the model paradigm. Clin Drug Investig 2005; 25: 153-164.
  14. Simons FE, Simons KJ, Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011; 128: 1139-1150.e1134.
  15. Bousquet J, Zuberbier T, Canonica GW, Fokkens WJ, Gopalan G, Shekar T. Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life. Allergy Asthma Proc 2013; 34: 274-282.
  16. Bernstein DI, Schwartz G, Bernstein JA, Allergic Rhinitis: Mechanisms and Treatment. Immunol Allergy Clin North Am 2016; 36: 261-278.
  17. Sogut A, Yilmaz O, Kirmaz C, Ozbilgin K, Onur E, Celik O, Pinar E, Vatansever S, Dinc G, Yuksel H. Regulatory-T, T-helper 1, and T-helper 2 cell differentiation in nasal mucosa of allergic rhinitis with olive pollen sensitivity. Int Arch Allergy Immunol 2012; 157: 349-353.
  18. Larosa DF, Orange JS, 1. Lymphocytes. J Allergy Clin Immunol 2008; 121: S364-369; quiz S412.
  19. Buckner JH, Ziegler SF, Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther 2004; 6: 215-222.
  20. Eifan AO, Durham SR., Pathogenesis of rhinitis. Clin Exp Allergy 2016; 46: 1139-1151.
  21. Meng Q, Li P, Li Y, et al., Broncho-vaxom alleviates persistent allergic rhinitis in patients by improving Th1/Th2 cytokine balance of nasal mucosa. Rhinology 2019; 57: 451-459.
  22. Paik Y, Dahl M, Fang D, Calhoun K. Update: the role of FoxP3 in allergic disease. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 275-279.
  23. Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, Green FH, Ackerman K, Haley K, Galle PR, Szabo SJ, Drazen JM. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002; 295: 336-338.
  24. McLaughlin T, Ackerman SE, Shen L, Engleman E. Role of innate and adaptive immunity in obesity-associated metabolic disease. J Clin Invest 2017; 127: 5-13.
  25. Romeo MJ, Agrawal R, Pomés A, et al., A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease. J Allergy Clin Immunol 2014; 133: 952-960.
  26. Wang J, Ma L, Yang S, Wang S, Wei X, Song S. IL-10-Expressing Th2 Cells Contribute to the Elevated Antibody Production in Rheumatoid Arthritis. Inflammation 2016; 39: 1017-1024.
  27. Li Y, Zhang W, [IL-6: the next key target for rheumatoid arthritis after TNF-α). Sheng Wu Gong Cheng Xue Bao 2017; 33: 36-43.
  28. Wei ST, Sun YH, Zong SH, Xiang YB. Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis. Med Sci Monit 2015; 21: 4030-4038.
  29. Yamak N, Yaykasli KO, Yilmaz U, Eroz R, Uzunlar AK, Ankaralı H, Sahiner C, Baltaci D. Association Between Survivin Gene Polymorphisms and the Susceptibility to Colon Cancer Development in Turkish Population, Asian Pac J Cancer Prev 2014; 15(20):8963-8967.
  30. Wei CC, Kung YJ, Chen CS, Chang CY, Lin CJ, Tien PT, Chang HY, Chen HJ, Huang YS, Lin HJ, Wan L. Allergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression. EBioMedicine 2018; 28: 274-286.
  31. Peng H, Wang J, Ye XY, Cheng J, Huang CZ, Li LY, Li TY, Li CW. Histamine H4 receptor regulates IL-6 and INF-γ secretion in native monocytes from healthy subjects and patients with allergic rhinitis. Clin Transl Allergy 2019; 9: 49.
  32. Bordbar M, Darvishzadeh R, Pazhouhandeh M, Kahrizi D. An overview of genome editing methods based on endonucleases. Modern Genetics J 2020; 15(2): 75-92.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 866 Download : 468

Most read articles by the same author(s)